242 related articles for article (PubMed ID: 28183848)
1. Long-term observation reveals high-frequency engraftment of human acute myeloid leukemia in immunodeficient mice.
Paczulla AM; Dirnhofer S; Konantz M; Medinger M; Salih HR; Rothfelder K; Tsakiris DA; Passweg JR; Lundberg P; Lengerke C
Haematologica; 2017 May; 102(5):854-864. PubMed ID: 28183848
[TBL] [Abstract][Full Text] [Related]
2. Identification of variables determining the engraftment potential of human acute myeloid leukemia in the immunodeficient NOD/SCID human chimera model.
Rombouts WJ; Martens AC; Ploemacher RE
Leukemia; 2000 May; 14(5):889-97. PubMed ID: 10803522
[TBL] [Abstract][Full Text] [Related]
3. Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors.
Feuring-Buske M; Gerhard B; Cashman J; Humphries RK; Eaves CJ; Hogge DE
Leukemia; 2003 Apr; 17(4):760-3. PubMed ID: 12682634
[TBL] [Abstract][Full Text] [Related]
4. A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia.
Bi L; Zhou B; Li H; He L; Wang C; Wang Z; Zhu L; Chen M; Gao S
BMC Cancer; 2018 Feb; 18(1):182. PubMed ID: 29439669
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a reproducible model of chronic-phase chronic myeloid leukemia in NOD/SCID mice using blood-derived mononuclear or CD34+ cells.
Lewis ID; McDiarmid LA; Samels LM; To LB; Hughes TP
Blood; 1998 Jan; 91(2):630-40. PubMed ID: 9427719
[TBL] [Abstract][Full Text] [Related]
6. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice.
Bonnet D; Bhatia M; Wang JC; Kapp U; Dick JE
Bone Marrow Transplant; 1999 Feb; 23(3):203-9. PubMed ID: 10084250
[TBL] [Abstract][Full Text] [Related]
7. Good engraftment of B-cell precursor ALL in NOD-SCID mice.
Baersch G; Möllers T; Hötte A; Dockhorn-Dworniczak B; Rübe C; Ritter J; Jürgens H; Vormoor J
Klin Padiatr; 1997; 209(4):178-85. PubMed ID: 9293448
[TBL] [Abstract][Full Text] [Related]
8. Human AML cells in NOD/SCID mice: engraftment potential and gene expression.
Lumkul R; Gorin NC; Malehorn MT; Hoehn GT; Zheng R; Baldwin B; Small D; Gore S; Smith D; Meltzer PS; Civin CI
Leukemia; 2002 Sep; 16(9):1818-26. PubMed ID: 12200698
[TBL] [Abstract][Full Text] [Related]
9. Engraftment of acute myeloid leukemia in NOD/SCID mice is independent of CXCR4 and predicts poor patient survival.
Monaco G; Konopleva M; Munsell M; Leysath C; Wang RY; Jackson CE; Korbling M; Estey E; Belmont J; Andreeff M
Stem Cells; 2004; 22(2):188-201. PubMed ID: 14990858
[TBL] [Abstract][Full Text] [Related]
10. Growth characteristics of acute myelogenous leukemia progenitors that initiate malignant hematopoiesis in nonobese diabetic/severe combined immunodeficient mice.
Ailles LE; Gerhard B; Kawagoe H; Hogge DE
Blood; 1999 Sep; 94(5):1761-72. PubMed ID: 10477702
[TBL] [Abstract][Full Text] [Related]
11. High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase.
Wang JC; Lapidot T; Cashman JD; Doedens M; Addy L; Sutherland DR; Nayar R; Laraya P; Minden M; Keating A; Eaves AC; Eaves CJ; Dick JE
Blood; 1998 Apr; 91(7):2406-14. PubMed ID: 9516140
[TBL] [Abstract][Full Text] [Related]
12. Engraftment of low numbers of pediatric acute lymphoid and myeloid leukemias into NOD/SCID/IL2Rcγnull mice reflects individual leukemogenecity and highly correlates with clinical outcome.
Woiterski J; Ebinger M; Witte KE; Goecke B; Heininger V; Philippek M; Bonin M; Schrauder A; Röttgers S; Herr W; Lang P; Handgretinger R; Hartwig UF; André MC
Int J Cancer; 2013 Oct; 133(7):1547-56. PubMed ID: 23526331
[TBL] [Abstract][Full Text] [Related]
13. Retroviral marking of acute myelogenous leukemia progenitors that initiate long-term culture and growth in immunodeficient mice.
Ailles LE; Humphries RK; Thomas TE; Hogge DE
Exp Hematol; 1999 Nov; 27(11):1609-20. PubMed ID: 10560908
[TBL] [Abstract][Full Text] [Related]
14. Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells.
Hogan CJ; Shpall EJ; McNiece I; Keller G
Biol Blood Marrow Transplant; 1997 Nov; 3(5):236-46. PubMed ID: 9450918
[TBL] [Abstract][Full Text] [Related]
15. AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML.
Pearce DJ; Taussig D; Zibara K; Smith LL; Ridler CM; Preudhomme C; Young BD; Rohatiner AZ; Lister TA; Bonnet D
Blood; 2006 Feb; 107(3):1166-73. PubMed ID: 16234360
[TBL] [Abstract][Full Text] [Related]
16. Identification of T-lymphocytic leukemia-initiating stem cells residing in a small subset of patients with acute myeloid leukemic disease.
Risueño RM; Campbell CJ; Dingwall S; Levadoux-Martin M; Leber B; Xenocostas A; Bhatia M
Blood; 2011 Jun; 117(26):7112-20. PubMed ID: 21562049
[TBL] [Abstract][Full Text] [Related]
17. Successful engraftment by leukemia initiating cells in adult acute lymphoblastic leukemia after direct intrahepatic injection into unconditioned newborn NOD/SCID mice.
Cheung AM; Fung TK; Fan AK; Wan TS; Chow HC; Leung JC; Chan LY; Kwong YL; Liang R; Leung AY
Exp Hematol; 2010 Jan; 38(1):3-10. PubMed ID: 19837128
[TBL] [Abstract][Full Text] [Related]
18. Growth pattern and clinical correlation of subcutaneously inoculated human primary acute leukemias in severe combined immunodeficiency mice.
Yan Y; Salomon O; McGuirk J; Dennig D; Fernandez J; Jagiello C; Nguyen H; Collins N; Steinherz P; O'Reilly RJ
Blood; 1996 Oct; 88(8):3137-46. PubMed ID: 8874214
[TBL] [Abstract][Full Text] [Related]
19. A robust xenotransplantation model for acute myeloid leukemia.
Sanchez PV; Perry RL; Sarry JE; Perl AE; Murphy K; Swider CR; Bagg A; Choi JK; Biegel JA; Danet-Desnoyers G; Carroll M
Leukemia; 2009 Nov; 23(11):2109-17. PubMed ID: 19626050
[TBL] [Abstract][Full Text] [Related]
20. RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia.
Snauwaert S; Vanhee S; Goetgeluk G; Verstichel G; Van Caeneghem Y; Velghe I; Philippé J; Berneman ZN; Plum J; Taghon T; Leclercq G; Thielemans K; Kerre T; Vandekerckhove B
Haematologica; 2012 Oct; 97(10):1539-47. PubMed ID: 22532518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
